$SRPT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sarepta Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Sarepta Therapeutics, Inc.. Get notifications about new insider transactions in Sarepta Therapeutics, Inc. for free.
Page: < prev 1 2 3 4 5 6 ... 8 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Option Exercise | M | 13.71 | 2,440 | 33,452 | 2,470 | |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Option Exercise | M | 13.71 | 2,440 | 33,452 | 2,470 | |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Option Exercise | M | 13.90 | 8,580 | 119,262 | 18,579 | |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Option Exercise | M | 13.90 | 8,580 | 119,262 | 18,579 | |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Option Exercise | M | 13.71 | 4,025 | 55,183 | 1,858 | |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Option Exercise | M | 13.71 | 4,025 | 55,183 | 1,858 | |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Option Exercise | M | 13.71 | 5,685 | 77,941 | 1,280 | |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Option Exercise | M | 13.71 | 5,685 | 77,941 | 1,280 | |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Payment of Exercise | F | 107.02 | 2,804 | 300,084 | 25,171 | 28 K to 25.2 K (-10.02 %) |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Payment of Exercise | F | 107.02 | 2,804 | 300,084 | 25,171 | 28 K to 25.2 K (-10.02 %) |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Buy | M | 23.85 | 7,900 | 188,415 | 27,975 | 20.1 K to 28 K (+39.35 %) |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Buy | M | 23.85 | 7,900 | 188,415 | 27,975 | 20.1 K to 28 K (+39.35 %) |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Buy | M | 13.90 | 5,590 | 77,701 | 20,075 | 14.5 K to 20.1 K (+38.59 %) |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Buy | M | 13.90 | 5,590 | 77,701 | 20,075 | 14.5 K to 20.1 K (+38.59 %) |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Buy | M | 13.71 | 52 | 713 | 14,485 | 14.4 K to 14.5 K (+0.36 %) |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Buy | M | 13.71 | 52 | 713 | 14,485 | 14.4 K to 14.5 K (+0.36 %) |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Buy | M | 13.71 | 2,440 | 33,452 | 14,433 | 12 K to 14.4 K (+20.35 %) |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Buy | M | 13.71 | 2,440 | 33,452 | 14,433 | 12 K to 14.4 K (+20.35 %) |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Sell | S | 105.00 | 2,957 | 310,485 | 11,993 | 15 K to 12 K (-19.78 %) |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Sell | S | 105.00 | 2,957 | 310,485 | 11,993 | 15 K to 12 K (-19.78 %) |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Sell | S | 105.00 | 3,753 | 394,065 | 14,950 | 18.7 K to 15 K (-20.07 %) |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Sell | S | 105.00 | 3,753 | 394,065 | 14,950 | 18.7 K to 15 K (-20.07 %) |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Sell | S | 105.00 | 18,290 | 1,920,450 | 18,703 | 37 K to 18.7 K (-49.44 %) |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Sell | S | 105.00 | 18,290 | 1,920,450 | 18,703 | 37 K to 18.7 K (-49.44 %) |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Buy | M | 13.90 | 8,580 | 119,262 | 36,993 | 28.4 K to 37 K (+30.20 %) |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Buy | M | 13.90 | 8,580 | 119,262 | 36,993 | 28.4 K to 37 K (+30.20 %) |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Buy | M | 13.71 | 4,025 | 55,183 | 28,413 | 24.4 K to 28.4 K (+16.50 %) |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Buy | M | 13.71 | 4,025 | 55,183 | 28,413 | 24.4 K to 28.4 K (+16.50 %) |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Buy | M | 13.71 | 5,685 | 77,941 | 24,388 | 18.7 K to 24.4 K (+30.40 %) |
| Nov 26 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Buy | M | 13.71 | 5,685 | 77,941 | 24,388 | 18.7 K to 24.4 K (+30.40 %) |
| Nov 20 2019 | SRPT | Sarepta Therapeuti ... | Ciambrone William | EVP | Option Exercise | A | 97.90 | 80,000 | 7,832,000 | 80,000 | |
| Sep 16 2019 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Buy | P | 87.49 | 3,309 | 289,504 | 3,187,065 | 3.2 M to 3.2 M (+0.10 %) |
| Sep 16 2019 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Buy | P | 87.49 | 1,691 | 147,950 | 3,183,756 | 3.2 M to 3.2 M (+0.05 %) |
| Sep 09 2019 | SRPT | Sarepta Therapeuti ... | BONNEY MICHAEL W | Director | Buy | P | 86.74 | 2,000 | 173,480 | 7,051 | 5.1 K to 7.1 K (+39.60 %) |
| Sep 06 2019 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Option Exercise | M | 7.80 | 5,000 | 39,000 | 0 | |
| Sep 06 2019 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Buy | P | 87.98 | 2,500 | 219,950 | 125,667 | 123.2 K to 125.7 K (+2.03 %) |
| Sep 06 2019 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Buy | M | 7.80 | 5,000 | 39,000 | 123,167 | 118.2 K to 123.2 K (+4.23 %) |
| Aug 22 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 23.85 | 100,000 | 2,385,000 | 0 | |
| Aug 22 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Gift | G | 0.00 | 42,535 | 0 | 30,179 | 72.7 K to 30.2 K (-58.50 %) |
| Aug 22 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Payment of Exercise | F | 101.50 | 57,465 | 5,832,698 | 72,714 | 130.2 K to 72.7 K (-44.14 %) |
| Aug 22 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 23.85 | 100,000 | 2,385,000 | 130,179 | 30.2 K to 130.2 K (+331.36 %) |
| Aug 20 2019 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Buy | P | 99.32 | 5,000 | 496,593 | 3,182,065 | 3.2 M to 3.2 M (+0.16 %) |
| Aug 15 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 13.71 | 260 | 3,565 | 218 | |
| Aug 15 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 13.71 | 985 | 13,504 | 2,385 | |
| Aug 15 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 13.90 | 2,625 | 36,488 | 0 | |
| Aug 15 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 29.03 | 3,021 | 87,700 | 0 | |
| Aug 15 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 34.92 | 2,863 | 99,976 | 0 | |
| Aug 15 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 13.71 | 260 | 3,565 | 30,179 | 29.9 K to 30.2 K (+0.87 %) |
| Aug 15 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 13.71 | 985 | 13,504 | 29,919 | 28.9 K to 29.9 K (+3.40 %) |
| Aug 15 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 13.90 | 2,625 | 36,488 | 28,934 | 26.3 K to 28.9 K (+9.98 %) |
| Aug 15 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 29.03 | 3,021 | 87,700 | 26,309 | 23.3 K to 26.3 K (+12.97 %) |
| Aug 15 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 34.92 | 2,863 | 99,976 | 23,288 | 20.4 K to 23.3 K (+14.02 %) |
| Aug 13 2019 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Buy | P | 122.50 | 1,300 | 159,250 | 3,173,365 | 3.2 M to 3.2 M (+0.04 %) |
| Aug 12 2019 | SRPT | Sarepta Therapeuti ... | INGRAM DOUGLAS S | President & CEO | Buy | P | 123.41 | 7,792 | 961,611 | 432,197 | 424.4 K to 432.2 K (+1.84 %) |
| Aug 12 2019 | SRPT | Sarepta Therapeuti ... | INGRAM DOUGLAS S | President & CEO | Buy | P | 122.76 | 8,460 | 1,038,550 | 424,405 | 415.9 K to 424.4 K (+2.03 %) |
| May 24 2019 | SRPT | Sarepta Therapeuti ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Option Exercise | M | 0.00 | 12,000 | 0 | 0 | |
| May 24 2019 | SRPT | Sarepta Therapeuti ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Payment of Exercise | F | 119.31 | 4,630 | 552,405 | 7,370 | 12 K to 7.4 K (-38.58 %) |
| May 24 2019 | SRPT | Sarepta Therapeuti ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Buy | M | 0.00 | 12,000 | 0 | 12,000 | 0 to 12 K |
| May 24 2019 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Option Exercise | M | 7.80 | 10,000 | 78,000 | 0 | |
| May 24 2019 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Sell | S | 120.00 | 10,000 | 1,200,000 | 11,717 | 21.7 K to 11.7 K (-46.05 %) |
| May 24 2019 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Buy | M | 7.80 | 10,000 | 78,000 | 21,717 | 11.7 K to 21.7 K (+85.35 %) |
| Mar 29 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Payment of Exercise | F | 118.68 | 2,953 | 350,462 | 20,425 | 23.4 K to 20.4 K (-12.63 %) |
| Mar 29 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Grant | A | 0.00 | 6,649 | 0 | 23,378 | 16.7 K to 23.4 K (+39.75 %) |
| Mar 29 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Payment of Exercise | F | 118.68 | 2,362 | 280,322 | 18,703 | 21.1 K to 18.7 K (-11.21 %) |
| Mar 29 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Grant | A | 0.00 | 5,319 | 0 | 21,065 | 15.7 K to 21.1 K (+33.78 %) |
| Mar 29 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | EVP, Chief Commerci ... | Payment of Exercise | F | 118.68 | 2,165 | 256,942 | 11,161 | 13.3 K to 11.2 K (-16.25 %) |
| Mar 29 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | EVP, Chief Commerci ... | Grant | A | 0.00 | 4,876 | 0 | 13,326 | 8.5 K to 13.3 K (+57.70 %) |
| Mar 20 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 13.71 | 43 | 590 | 478 | |
| Mar 20 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 13.71 | 164 | 2,248 | 3,370 | |
| Mar 20 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 13.90 | 3,511 | 48,803 | 2,625 | |
| Mar 20 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 23.85 | 11,768 | 280,667 | 0 | |
| Mar 20 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Payment of Exercise | F | 126.47 | 2,625 | 331,984 | 16,729 | 19.4 K to 16.7 K (-13.56 %) |
| Mar 20 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 13.71 | 43 | 590 | 19,354 | 19.3 K to 19.4 K (+0.22 %) |
| Mar 20 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 13.71 | 164 | 2,248 | 19,311 | 19.1 K to 19.3 K (+0.86 %) |
| Mar 20 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 13.90 | 3,511 | 48,803 | 19,147 | 15.6 K to 19.1 K (+22.45 %) |
| Mar 20 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 23.85 | 11,768 | 280,667 | 15,636 | 3.9 K to 15.6 K (+304.24 %) |
| Mar 04 2019 | SRPT | Sarepta Therapeuti ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Option Exercise | A | 145.48 | 55,000 | 8,001,400 | 55,000 | |
| Mar 04 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | A | 145.48 | 55,000 | 8,001,400 | 55,000 | |
| Mar 04 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Sell | D | 0.00 | 4,781 | 0 | 3,868 | 8.6 K to 3.9 K (-55.28 %) |
| Mar 04 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Option Exercise | A | 145.48 | 45,000 | 6,546,600 | 45,000 | |
| Mar 04 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | EVP, General Counse ... | Sell | D | 0.00 | 3,825 | 0 | 15,746 | 19.6 K to 15.7 K (-19.54 %) |
| Mar 04 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | EVP, Chief Commerci ... | Option Exercise | A | 145.48 | 45,000 | 6,546,600 | 45,000 | |
| Mar 04 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | EVP, Chief Commerci ... | Sell | D | 0.00 | 3,375 | 0 | 8,450 | 11.8 K to 8.5 K (-28.54 %) |
| Mar 04 2019 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Option Exercise | A | 145.48 | 3,213 | 467,427 | 3,213 | |
| Mar 04 2019 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Grant | A | 0.00 | 1,633 | 0 | 11,717 | 10.1 K to 11.7 K (+16.19 %) |
| Mar 04 2019 | SRPT | Sarepta Therapeuti ... | Nicaise Claude | Director | Option Exercise | A | 145.48 | 3,213 | 467,427 | 3,213 | |
| Mar 04 2019 | SRPT | Sarepta Therapeuti ... | Nicaise Claude | Director | Grant | A | 0.00 | 1,633 | 0 | 7,051 | 5.4 K to 7.1 K (+30.14 %) |
| Mar 04 2019 | SRPT | Sarepta Therapeuti ... | GRAY MARY ANN | Director | Option Exercise | A | 145.48 | 3,213 | 467,427 | 3,213 | |
| Mar 04 2019 | SRPT | Sarepta Therapeuti ... | GRAY MARY ANN | Director | Grant | A | 0.00 | 1,633 | 0 | 1,701 | 68 to 1.7 K (+2,401.47 %) |
| Mar 04 2019 | SRPT | Sarepta Therapeuti ... | BONNEY MICHAEL W | Director | Option Exercise | A | 145.48 | 3,213 | 467,427 | 3,213 | |
| Mar 04 2019 | SRPT | Sarepta Therapeuti ... | BONNEY MICHAEL W | Director | Grant | A | 0.00 | 1,633 | 0 | 5,051 | 3.4 K to 5.1 K (+47.78 %) |
| Mar 04 2019 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Option Exercise | A | 145.48 | 3,213 | 467,427 | 3,213 | |
| Mar 04 2019 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Grant | A | 0.00 | 1,633 | 0 | 118,167 | 116.5 K to 118.2 K (+1.40 %) |
| Mar 04 2019 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Option Exercise | A | 145.48 | 3,213 | 467,427 | 3,213 | |
| Mar 04 2019 | SRPT | Sarepta Therapeuti ... | Barry Richard | Director | Grant | A | 0.00 | 1,633 | 0 | 3,172,065 | 3.2 M to 3.2 M (+0.05 %) |
| Feb 08 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 23.85 | 65,000 | 1,550,250 | 10,466 | |
| Feb 08 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Sell | S | 145.00 | 65,000 | 9,425,000 | 8,649 | 73.6 K to 8.6 K (-88.26 %) |
| Feb 08 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 23.85 | 65,000 | 1,550,250 | 73,649 | 8.6 K to 73.6 K (+751.53 %) |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 23.85 | 21,198 | 505,572 | 75,466 | |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 23.85 | 19,345 | 461,378 | 96,664 | |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 13.90 | 17,860 | 248,254 | 0 | |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 13.71 | 1,128 | 15,465 | 6,771 | |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 13.71 | 5,469 | 74,980 | 7,404 | |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Sell | S | 130.72 | 21,198 | 2,771,003 | 8,649 | 29.8 K to 8.6 K (-71.02 %) |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 23.85 | 21,198 | 505,572 | 29,847 | 8.6 K to 29.8 K (+245.09 %) |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Sell | S | 130.00 | 43,802 | 5,694,260 | 8,649 | 52.5 K to 8.6 K (-83.51 %) |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 23.85 | 19,345 | 461,378 | 52,451 | 33.1 K to 52.5 K (+58.43 %) |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 13.90 | 17,860 | 248,254 | 33,106 | 15.2 K to 33.1 K (+117.15 %) |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 13.71 | 1,128 | 15,465 | 15,246 | 14.1 K to 15.2 K (+7.99 %) |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 13.71 | 5,469 | 74,980 | 14,118 | 8.6 K to 14.1 K (+63.23 %) |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 26.24 | 5,250 | 137,760 | 46,965 | |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Option Exercise | M | 13.90 | 2,250 | 31,275 | 0 | |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Sell | S | 140.00 | 15,000 | 2,100,000 | 15,266 | 30.3 K to 15.3 K (-49.56 %) |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 26.24 | 5,250 | 137,760 | 30,266 | 25 K to 30.3 K (+20.99 %) |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Cumbo Alexander | SVP, Chief Commerci ... | Buy | M | 13.90 | 2,250 | 31,275 | 25,016 | 22.8 K to 25 K (+9.88 %) |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | M | 23.85 | 16,827 | 401,324 | 116,405 | |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | M | 13.71 | 1,548 | 21,223 | 5,883 | |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Option Exercise | M | 13.71 | 3,125 | 42,844 | 6,965 | |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Sell | S | 140.00 | 30,000 | 4,200,000 | 19,571 | 49.6 K to 19.6 K (-60.52 %) |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Buy | M | 23.85 | 16,827 | 401,324 | 49,571 | 32.7 K to 49.6 K (+51.39 %) |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Buy | M | 13.71 | 1,548 | 21,223 | 32,744 | 31.2 K to 32.7 K (+4.96 %) |
| Feb 01 2019 | SRPT | Sarepta Therapeuti ... | Howton David T | SVP, General Counse ... | Buy | M | 13.71 | 3,125 | 42,844 | 31,196 | 28.1 K to 31.2 K (+11.13 %) |
| Dec 11 2018 | SRPT | Sarepta Therapeuti ... | GRAY MARY ANN | Director | Option Exercise | A | 0.00 | 2,901 | 0 | 2,901 | |
| Dec 11 2018 | SRPT | Sarepta Therapeuti ... | GRAY MARY ANN | Director | Option Exercise | A | 122.80 | 5,711 | 701,311 | 5,711 | |
| Nov 02 2018 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Option Exercise | M | 8.94 | 6,667 | 59,603 | 0 | |
| Nov 02 2018 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Sell | S | 140.50 | 6,667 | 936,714 | 10,084 | 16.8 K to 10.1 K (-39.80 %) |
| Nov 02 2018 | SRPT | Sarepta Therapeuti ... | Wigzell Hans Lennart Rudolf | Director | Buy | M | 8.94 | 6,667 | 59,603 | 16,751 | 10.1 K to 16.8 K (+66.11 %) |
| Nov 02 2018 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Option Exercise | M | 3.96 | 10,000 | 39,600 | 0 | |
| Nov 02 2018 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Sell | S | 131.71 | 10,000 | 1,317,100 | 116,534 | 126.5 K to 116.5 K (-7.90 %) |
| Nov 02 2018 | SRPT | Sarepta Therapeuti ... | BEHRENS M KATHLEEN | Director | Buy | M | 3.96 | 10,000 | 39,600 | 126,534 | 116.5 K to 126.5 K (+8.58 %) |
| Oct 30 2018 | SRPT | Sarepta Therapeuti ... | INGRAM DOUGLAS S | President & CEO | Buy | P | 120.94 | 3,134 | 379,026 | 415,945 | 412.8 K to 415.9 K (+0.76 %) |
| Oct 30 2018 | SRPT | Sarepta Therapeuti ... | INGRAM DOUGLAS S | President & CEO | Buy | P | 120.26 | 13,561 | 1,630,846 | 412,811 | 399.3 K to 412.8 K (+3.40 %) |
| Oct 26 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 13.71 | 11,718 | 160,654 | 12,873 | |
| Oct 26 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 13.71 | 29,080 | 398,687 | 7,899 | |
| Oct 26 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 13.90 | 39,006 | 542,183 | 17,860 | |
| Oct 26 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 23.85 | 9,596 | 228,865 | 116,009 | |
| Oct 26 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Gift | G | 0.00 | 12,012 | 0 | 12,012 | 0 to 12 K |
| Oct 26 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Gift | G | 0.00 | 12,012 | 0 | 8,649 | 20.7 K to 8.6 K (-58.14 %) |
| Oct 26 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Sell | S | 127.74 | 107,524 | 13,735,116 | 20,661 | 128.2 K to 20.7 K (-83.88 %) |
| Oct 26 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 13.71 | 11,718 | 160,654 | 128,185 | 116.5 K to 128.2 K (+10.06 %) |
| Oct 26 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 13.71 | 29,080 | 398,687 | 116,467 | 87.4 K to 116.5 K (+33.28 %) |
| Oct 26 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 13.90 | 39,006 | 542,183 | 87,387 | 48.4 K to 87.4 K (+80.62 %) |
| Oct 26 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Buy | M | 23.85 | 9,596 | 228,865 | 48,381 | 38.8 K to 48.4 K (+24.74 %) |
| Oct 26 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 13.71 | 11,718 | 160,654 | 12,873 | |
| Oct 26 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 13.71 | 29,080 | 398,687 | 7,899 | |
| Oct 26 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 13.90 | 39,006 | 542,183 | 17,860 | |
| Oct 26 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Option Exercise | M | 23.85 | 9,596 | 228,865 | 116,009 | |
| Oct 26 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Gift | G | 0.00 | 12,012 | 0 | 12,012 | 0 to 12 K |
| Oct 26 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Gift | G | 0.00 | 12,012 | 0 | 8,649 | 20.7 K to 8.6 K (-58.14 %) |
| Oct 26 2018 | SRPT | Sarepta Therapeuti ... | Mahatme Sandesh | EVP, CFO & CBO | Sell | S | 127.74 | 107,524 | 13,735,116 | 20,661 | 128.2 K to 20.7 K (-83.88 %) |